Hologic Operating Income from 2010 to 2024

HOLX Stock

USD 79.73 0.76 0.96%

Hologic Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Hologic generates from its operations. View All Fundamentals

Operating Income

First Reported

1988-12-31

Previous Quarter

263.9 M

Current Value

230.1 M

Quarterly Volatility

281.7 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 324.4 M, Interest Expense of 74.8 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 5.0, Dividend Yield of 0.0 or PTB Ratio of 3.56. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.

Check out the analysis of Hologic Correlation against competitors.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Operating Income Growth Pattern

Below is the plot of the Operating Income of Hologic over the last few years. Operating Income is the amount of profit realized from Hologic operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Hologic is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Hologic's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Hologic Operating Income Regression Statistics

	Arithmetic Mean	630,831,000
	Geometric Mean	405,489,073
	Coefficient Of Variation	130.93
	Mean Deviation	621,015,067
	Median	548,600,000
	Standard Deviation	825,972,244
	Sample Variance	682230.1T
	Range	3.4B
	R-Value	0.59
	Mean Square Error	481545.1T
	R-Squared	0.34
	Significance	0.02
	Slope	108,416,136
	Total Sum of Squares	9551222.1T

Hologic Operating Income History

	2024	926.7 M
	2023	882.6 M
	2022	668.4 M
	2021	1.6 B
	2020	2.5 B
	2019	1.1 B
	2018	134.4 M

Other Fundumenentals of Hologic

Non Operating Income Net Other

Hologic Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Short Term Investments	Common Stock	Long Term Debt	Treasury Stock	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.71	0.28	0.08	0.51	0.69	0.63	0.37	0.08	0.14	0.8	0.75	-0.36	0.5	0.8	0.71	0.91	0.07	0.6	0.57	-0.03	-0.75	0.02	-0.24	-0.14	0.37	0.31
Total Stockholder Equity	0.71		-0.46	0.73	0.58	0.0	0.97	0.71	-0.19	0.57	0.53	0.13	-0.88	-0.21	0.59	0.65	0.61	0.73	0.05	0.84	-0.63	-0.46	-0.02	-0.46	-0.4	0.9	0.71
Net Debt	0.28	-0.46		-0.9	-0.06	0.85	-0.55	-0.49	0.39	-0.61	0.3	0.74	0.73	0.9	0.22	0.04	0.33	-0.9	0.64	-0.41	0.78	-0.33	0.13	0.3	0.41	-0.76	-0.58
Retained Earnings	0.08	0.73	-0.9		0.24	-0.61	0.77	0.6	-0.43	0.69	-0.09	-0.46	-0.87	-0.72	0.04	0.13	0.01	0.92	-0.36	0.58	-0.74	0.19	-0.19	-0.39	-0.41	0.9	0.71
Net Receivables	0.51	0.58	-0.06	0.24		0.16	0.6	0.3	0.14	0.12	0.64	0.15	-0.64	-0.16	0.62	0.77	0.51	0.45	-0.11	0.6	-0.61	-0.66	0.17	-0.37	-0.05	0.49	0.2
Total Liab	0.69	0.0	0.85	-0.61	0.16		-0.08	-0.28	0.32	-0.48	0.67	0.94	0.34	0.88	0.64	0.43	0.73	-0.63	0.76	0.0	0.57	-0.62	0.05	0.1	0.2	-0.38	-0.3
Total Current Assets	0.63	0.97	-0.55	0.77	0.6	-0.08		0.67	-0.25	0.56	0.49	0.06	-0.93	-0.33	0.55	0.63	0.51	0.8	0.0	0.84	-0.71	-0.44	-0.13	-0.41	-0.42	0.94	0.69
Accounts Payable	0.37	0.71	-0.49	0.6	0.3	-0.28	0.67		-0.28	0.93	0.21	-0.11	-0.6	-0.27	0.24	0.3	0.22	0.66	-0.02	0.79	-0.56	-0.15	0.04	-0.28	-0.57	0.75	0.93
Short Term Debt	0.08	-0.19	0.39	-0.43	0.14	0.32	-0.25	-0.28		-0.44	0.28	0.01	0.26	0.31	0.22	0.24	0.16	-0.32	-0.25	-0.17	0.19	-0.4	0.86	-0.26	0.15	-0.39	-0.38
Short Term Investments	0.14	0.57	-0.61	0.69	0.12	-0.48	0.56	0.93	-0.44		-0.09	-0.27	-0.55	-0.4	-0.01	0.02	-0.02	0.67	-0.07	0.65	-0.5	0.17	-0.13	-0.23	-0.52	0.72	0.93
Common Stock	0.8	0.53	0.3	-0.09	0.64	0.67	0.49	0.21	0.28	-0.09		0.63	-0.33	0.32	0.96	0.95	0.9	0.08	0.3	0.64	-0.19	-0.89	0.2	-0.26	-0.17	0.25	0.19
Long Term Debt	0.75	0.13	0.74	-0.46	0.15	0.94	0.06	-0.11	0.01	-0.27	0.63		0.22	0.82	0.62	0.4	0.74	-0.51	0.9	0.12	0.49	-0.56	-0.22	0.19	0.09	-0.2	-0.12
Treasury Stock	-0.36	-0.88	0.73	-0.87	-0.64	0.34	-0.93	-0.6	0.26	-0.55	-0.33	0.22		0.61	-0.39	-0.56	-0.3	-0.93	0.31	-0.79	0.89	0.27	0.1	0.45	0.38	-0.96	-0.64
Intangible Assets	0.5	-0.21	0.9	-0.72	-0.16	0.88	-0.33	-0.27	0.31	-0.4	0.32	0.82	0.61		0.26	0.04	0.45	-0.81	0.78	-0.28	0.8	-0.38	0.09	0.16	0.32	-0.57	-0.36
Property Plant Equipment	0.8	0.59	0.22	0.04	0.62	0.64	0.55	0.24	0.22	-0.01	0.96	0.62	-0.39	0.26		0.92	0.93	0.13	0.34	0.69	-0.18	-0.76	0.15	-0.24	-0.3	0.32	0.3
Current Deferred Revenue	0.71	0.65	0.04	0.13	0.77	0.43	0.63	0.3	0.24	0.02	0.95	0.4	-0.56	0.04	0.92		0.81	0.34	0.05	0.75	-0.46	-0.85	0.24	-0.34	-0.24	0.45	0.29
Good Will	0.91	0.61	0.33	0.01	0.51	0.73	0.51	0.22	0.16	-0.02	0.9	0.74	-0.3	0.45	0.93	0.81		0.01	0.51	0.58	-0.01	-0.71	0.11	-0.24	-0.15	0.26	0.25
Net Tangible Assets	0.07	0.73	-0.9	0.92	0.45	-0.63	0.8	0.66	-0.32	0.67	0.08	-0.51	-0.93	-0.81	0.13	0.34	0.01		-0.51	0.7	-0.94	-0.04	-0.07	-0.39	-0.46	0.93	0.69
Long Term Debt Total	0.6	0.05	0.64	-0.36	-0.11	0.76	0.0	-0.02	-0.25	-0.07	0.3	0.9	0.31	0.78	0.34	0.05	0.51	-0.51		0.01	0.6	-0.23	-0.43	0.34	0.01	-0.19	-0.01
Capital Surpluse	0.57	0.84	-0.41	0.58	0.6	0.0	0.84	0.79	-0.17	0.65	0.64	0.12	-0.79	-0.28	0.69	0.75	0.58	0.7	0.01		-0.66	-0.47	0.0	-0.35	-0.56	0.82	0.83
Deferred Long Term Liab	-0.03	-0.63	0.78	-0.74	-0.61	0.57	-0.71	-0.56	0.19	-0.5	-0.19	0.49	0.89	0.8	-0.18	-0.46	-0.01	-0.94	0.6	-0.66		0.18	-0.04	0.34	0.37	-0.83	-0.53
Accumulated Depreciation	-0.75	-0.46	-0.33	0.19	-0.66	-0.62	-0.44	-0.15	-0.4	0.17	-0.89	-0.56	0.27	-0.38	-0.76	-0.85	-0.71	-0.04	-0.23	-0.47	0.18		-0.26	0.25	0.01	-0.19	-0.01
Short Long Term Debt	0.02	-0.02	0.13	-0.19	0.17	0.05	-0.13	0.04	0.86	-0.13	0.2	-0.22	0.1	0.09	0.15	0.24	0.11	-0.07	-0.43	0.0	-0.04	-0.26		-0.39	-0.05	-0.19	-0.11
Long Term Investments	-0.24	-0.46	0.3	-0.39	-0.37	0.1	-0.41	-0.28	-0.26	-0.23	-0.26	0.19	0.45	0.16	-0.24	-0.34	-0.24	-0.39	0.34	-0.35	0.34	0.25	-0.39		-0.05	-0.35	-0.26
Net Invested Capital	-0.14	-0.4	0.41	-0.41	-0.05	0.2	-0.42	-0.57	0.15	-0.52	-0.17	0.09	0.38	0.32	-0.3	-0.24	-0.15	-0.46	0.01	-0.56	0.37	0.01	-0.05	-0.05		-0.48	-0.63
Net Working Capital	0.37	0.9	-0.76	0.9	0.49	-0.38	0.94	0.75	-0.39	0.72	0.25	-0.2	-0.96	-0.57	0.32	0.45	0.26	0.93	-0.19	0.82	-0.83	-0.19	-0.19	-0.35	-0.48		0.79
Capital Stock	0.31	0.71	-0.58	0.71	0.2	-0.3	0.69	0.93	-0.38	0.93	0.19	-0.12	-0.64	-0.36	0.3	0.29	0.25	0.69	-0.01	0.83	-0.53	-0.01	-0.11	-0.26	-0.63	0.79

Click cells to compare fundamentals

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	882.6 M	926.7 M
Non Operating Income Net Other	49.6 M	52 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hologic Operating Income from 2010 to 2024

Latest Hologic's Operating Income Growth Pattern

Hologic Operating Income Regression Statistics

Hologic Operating Income History

Other Fundumenentals of Hologic

Hologic Operating Income component correlations

About Hologic Financial Statements

Also Currently Popular

Additional Tools for Hologic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY